Edgewise Therapeutics Inc
EWTX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.85B
Close$
$0.56
98.8% downside
Current Fair Value
98.8% downsideOvervalued by 98.8% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $4.85 Billion |
|---|---|
| Enterprise Value | $4.79 Billion |
| Earnings per Share | $-1.63 |
| Beta | 0.28 |
| Outstanding Shares | 108,870,331 |
Return
| Return on Equity | 61.84% |
|---|---|
| Return on Assets | 56.72% |
| Return on Invested Capital | 70.90% |
Valuation & Multiples
| P/E Ratio | 4.87 |
|---|---|
| PEG | -0.16 |
| Price to Sales | - |
| Price to Book Ratio | 3.28 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 4.13 |
| Enterprise Value to Net Income | 4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 5, 2026
EPS Estimate
-$0.52
Consensus analyst estimateRevenue Estimate
$119.23 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 25, 2027
EPS Estimate
-$0.43
Consensus analyst estimateRevenue Estimate
$9.62 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 48.67% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 6.06%▼ 105.79% |
|---|---|
| Total Invested | $264.88M▼ 94.54% |
| Investors Holding | 69▼ 169.00% |
About Edgewise Therapeutics Inc
19 employees
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need....